Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
Denmark
/
Healthcare
/
Ambu
AMBU B
Ambu
Global Competition And Regulatory Hurdles Will Depress Endoscopy Demand
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 7 Analysts
Published
02 Jul 25
Updated
02 Jul 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
DKK 94.54
3.2% undervalued
intrinsic discount
02 Jul
DKK 91.50
Loading
1Y
-31.6%
7D
-8.7%
Author's Valuation
DKK 94.5
3.2% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
DKK 94.5
3.2% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-42m
8b
2014
2017
2020
2023
2025
2026
2028
Revenue DKK 7.9b
Earnings DKK 1.2b
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
9.98%
Medical Equipment revenue growth rate
0.32%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
5.60%
Calculation
DKK 1.15b
Earnings '28
x
25.23x
PE Ratio '28
=
DKK 29.08b
Market Cap '28
DKK 29.08b
Market Cap '28
/
260.04m
No. shares '28
=
DKK 111.83
Share Price '28
DKK 111.83
Share Price '28
Discounted to 2025 @ 5.63% p.a.
=
DKK 94.89
Fair Value '25
